SCHEMBL6987665

SCHEMBL6987665

Cc1ccc(C2=Nc3ccc(C#N)cc3C(=O)C2)cc1

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MAPT P10636 3/20 0.39
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 2/20 0.39
NPC1 O15118 2/20 0.39
PKM P14618 2/20 0.39
CYP2A6 P11509 1/20 0.39
RXFP1 Q9HBX9 1/20 0.38
HTT P42858 1/20 0.37
KMT2A Q03164 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
AR P10275 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9180114 0.80 CASP3 (0.39) ALDH1A1CYP2A6KMT2A
SCHEMBL8477327 0.79 ALDH1A1 (0.44) RAB9ASMN1; SMN2MAPTALDH1A1KDM4E
SCHEMBL10747888 0.76 STK10 (0.44) SMN1; SMN2MAPTALDH1A1KDM4EHTT
SCHEMBL9182853 0.74 CASP3 (0.36) CYP2A6
SCHEMBL9874776 0.71 RXFP1 (0.52) RAB9ASMN1; SMN2MAPTALDH1A1KDM4E
SCHEMBL9874038 0.71 MAPT (0.44) RAB9ASMN1; SMN2MAPTALDH1A1KDM4E
SCHEMBL28681845 0.70 MMP3 (0.41) AR
SCHEMBL31490586 0.70 RXFP1 (0.44) RAB9ASMN1; SMN2MAPTNPC1RXFP1
SCHEMBL5869331 0.69 RAB9A (0.60) RAB9ASMN1; SMN2
SCHEMBL16781504 0.67 MAPT (0.54) RAB9ASMN1; SMN2MAPTALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1276739-A2 HETEROCYCLES THAT ARE INHIBITORS OF IMPDH ENZYME Bristol-Myers Squibb Company (US) 2003-01-22 EP disclosed
WO-2001081340-A2 HETEROCYCLES THAT ARE INHIBITORS OF IMPDH ENZYME BRISTOL-MYERS SQUIBB COMPANY (US) 2001-11-01 WO disclosed